Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Avanos Medical Q2 Adj. EPS $0.24 Misses $0.30 Estimate, Sales $169.40M Miss $186.22M Estimate

Author: Benzinga Newsdesk | August 09, 2023 07:04am

Avanos Medical (NYSE:AVNS) reported adjusted quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.30 by 20 percent. This is a 41.46 percent decrease over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $169.40 million which missed the analyst consensus estimate of $186.22 million by 9.03 percent. This is a 16.55 percent decrease over sales of $203.00 million the same period last year.

Posted In: AVNS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist